Yu Li Selected Research

vMIP-II

10/2018	The N-terminal polypeptide derived from vMIP-II exerts its anti-tumor activity in human breast cancer by regulating lncRNA SPRY4-IT1.
4/2017	N-terminal polypeptide derived from vMIP-II exerts its antitumor activity by inhibiting the CXCR4 pathway in human glioma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yu Li Research Topics

Disease

360	Neoplasms (Cancer) 05/2024 - 07/2002
106	Inflammation (Inflammations) 02/2024 - 10/2009
83	Infections 05/2024 - 09/2002
73	Neoplasm Metastasis (Metastasis) 12/2023 - 06/2002
51	Hepatocellular Carcinoma (Hepatoma) 12/2023 - 08/2002
48	Breast Neoplasms (Breast Cancer) 10/2023 - 11/2002
47	Insulin Resistance 01/2024 - 10/2004
46	Obesity 12/2023 - 10/2004
40	Fibrosis (Cirrhosis) 04/2024 - 02/2007
37	Hypoxia (Hypoxemia) 03/2024 - 05/2009
35	Alzheimer Disease (Alzheimer's Disease) 02/2024 - 02/2006
32	Lung Neoplasms (Lung Cancer) 02/2024 - 11/2003
32	Adenocarcinoma of Lung 01/2024 - 06/2002
27	Carcinogenesis 02/2024 - 02/2004
24	Body Weight (Weight, Body) 05/2024 - 02/2006
24	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2024 - 07/2005
23	COVID-19 11/2023 - 01/2020
23	Atherosclerosis 04/2023 - 04/2011
21	Type 2 Diabetes Mellitus (MODY) 05/2024 - 04/2011
20	Non-alcoholic Fatty Liver Disease 02/2024 - 01/2014
20	Fatty Liver 02/2024 - 01/2013
20	Ischemia 10/2023 - 11/2010
19	Osteoporosis 01/2023 - 03/2013
18	Pain (Aches) 03/2024 - 02/2005
18	Hypertension (High Blood Pressure) 12/2023 - 01/2014
17	Stomach Neoplasms (Stomach Cancer) 01/2024 - 12/2008
17	Pneumonia (Pneumonitis) 10/2023 - 10/2013
17	Adenocarcinoma 10/2023 - 12/2015
16	Colonic Neoplasms (Colon Cancer) 02/2024 - 01/2004
16	Cognitive Dysfunction 12/2023 - 07/2012
16	Prostatic Neoplasms (Prostate Cancer) 11/2023 - 11/2011
16	Glioma (Gliomas) 03/2023 - 01/2012
15	Wounds and Injuries (Trauma) 02/2024 - 09/2011
15	Colorectal Neoplasms (Colorectal Cancer) 12/2023 - 05/2004
15	Carcinoma (Carcinomatosis) 11/2023 - 06/2002
15	Reperfusion Injury 11/2023 - 11/2010
13	Liver Cirrhosis (Hepatic Cirrhosis) 04/2024 - 11/2005
13	Chronic Obstructive Pulmonary Disease (COPD) 10/2023 - 12/2008
12	Mitochondrial Diseases (Mitochondrial Disease) 08/2023 - 01/2016
11	Stroke (Strokes) 03/2024 - 06/2014
11	Liver Diseases (Liver Disease) 02/2024 - 09/2002
11	Liver Neoplasms (Liver Cancer) 12/2023 - 10/2015
11	Hyperlipidemias (Hyperlipidemia) 10/2023 - 04/2011
11	Necrosis 11/2022 - 08/2006
11	Hypersensitivity (Allergy) 01/2022 - 05/2014
11	Brain Injuries (Brain Injury) 12/2021 - 01/2012
10	Myocardial Infarction 03/2024 - 03/2007

Drug/Important Bio-Agent (IBA)

153	Proteins (Proteins, Gene)FDA Link 03/2024 - 06/2003
72	Biomarkers (Surrogate Marker)IBA 04/2024 - 10/2008
62	Glucose (Dextrose)FDA LinkGeneric 05/2024 - 10/2007
57	LipidsIBA 03/2024 - 04/2011
57	Messenger RNA (mRNA)IBA 01/2024 - 06/2003
56	MicroRNAs (MicroRNA)IBA 12/2023 - 08/2009
40	Therapeutic UsesIBA 01/2024 - 07/2004
28	AntigensIBA 03/2024 - 07/2002
27	RNA (Ribonucleic Acid)IBA 03/2024 - 01/2018
27	VaccinesIBA 11/2023 - 05/2006
26	CytokinesIBA 04/2024 - 04/2010
25	Anti-Bacterial Agents (Antibiotics)IBA 05/2024 - 12/2010
25	Insulin (Novolin)FDA Link 01/2024 - 10/2004
24	Peptides (Polypeptides)IBA 04/2024 - 03/2003
24	Long Noncoding RNAIBA 01/2023 - 02/2015
23	DNA (Deoxyribonucleic Acid)IBA 01/2023 - 09/2002
22	AntioxidantsIBA 07/2023 - 11/2015
22	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2022 - 07/2005
21	EnzymesIBA 01/2024 - 01/2011
20	LipopolysaccharidesIBA 02/2024 - 06/2007
17	Interleukin-6 (Interleukin 6)IBA 03/2024 - 01/2013
17	Amyloid (Amyloid Fibrils)IBA 02/2024 - 08/2003
17	CholesterolIBA 02/2024 - 01/2013
16	Oxygen (Dioxygen)IBA 10/2023 - 03/2014
16	AntibodiesIBA 01/2023 - 05/2006
16	Small Interfering RNA (siRNA)IBA 01/2023 - 05/2012
15	Polysaccharides (Glycans)IBA 01/2024 - 10/2008
14	Reactive Oxygen Species (Oxygen Radicals)IBA 05/2024 - 07/2014
14	Antiviral Agents (Antivirals)IBA 01/2024 - 10/2012
14	Blood Glucose (Blood Sugar)IBA 01/2023 - 10/2009
14	CurcuminIBA 01/2022 - 04/2011
13	CateninsIBA 02/2024 - 04/2011
13	CollagenIBA 01/2024 - 01/2020
13	Transcription Factors (Transcription Factor)IBA 12/2023 - 09/2012
13	Circular RNAIBA 10/2023 - 11/2018
13	AcidsIBA 06/2023 - 10/2007
12	CalciumIBA 03/2024 - 02/2013
12	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 11/2021 - 04/2010
11	Protein Kinases (Protein Kinase)IBA 01/2024 - 10/2004
11	Triglycerides (Triacylglycerol)IBA 12/2023 - 11/2008
11	Matrix Metalloproteinases (MMPs)IBA 12/2023 - 04/2006
11	Estrogen ReceptorsIBA 11/2023 - 10/2010
11	Fatty Acids (Saturated Fatty Acids)IBA 01/2020 - 10/2009
10	ErbB Receptors (EGF Receptor)IBA 11/2023 - 12/2004
10	Estrogens (Estrogen)FDA Link 11/2023 - 03/2009

Therapy/Procedure

158	Therapeutics 05/2024 - 01/2004
42	Drug Therapy (Chemotherapy) 05/2024 - 02/2005
34	Immunotherapy 05/2024 - 10/2003
32	Chinese Traditional Medicine (Traditional Chinese Medicine) 02/2024 - 05/2014
11	Stents 09/2023 - 03/2007
10	Ligation 03/2024 - 07/2014
10	Length of Stay 01/2024 - 12/2015
10	Photochemotherapy (Photodynamic Therapy) 12/2023 - 07/2019